These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
93 related items for PubMed ID: 24418373
1. MTHFR polymorphism and risk of periprocedural myocardial infarction after coronary stenting. Verdoia M, Schaffer A, Cassetti E, Barbieri L, Di Giovine G, Marino P, De Luca G, Novara Atherosclerosis Study Group (NAS). Nutr Metab Cardiovasc Dis; 2014 May; 24(5):532-7. PubMed ID: 24418373 [Abstract] [Full Text] [Related]
3. Mean platelet volume and the risk of periprocedural myocardial infarction in patients undergoing coronary angioplasty. Verdoia M, Camaro C, Barbieri L, Schaffer A, Marino P, Bellomo G, Suryapranata H, De Luca G. Atherosclerosis; 2013 May; 228(1):136-41. PubMed ID: 23518179 [Abstract] [Full Text] [Related]
4. Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI. Verdoia M, Secco GG, Barbieri L, Cassetti E, Schaffer A, Sinigaglia F, Marino P, Suryapranata H, De Luca G, Novara Atherosreclerosis Study Group (NAS). Platelets; 2014 May; 25(5):367-72. PubMed ID: 24283589 [Abstract] [Full Text] [Related]
7. Impact of pre-procedural dual antiplatelet therapy on periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions with adjunctive tirofiban. Verdoia M, Pergolini P, Barbieri L, Rolla R, Nardin M, Negro F, Suryapranata H, De Luca G, Novara Atherosclerosis Study Group (NAS). Thromb Res; 2018 Apr; 164():17-23. PubMed ID: 29475177 [Abstract] [Full Text] [Related]
8. Platelet distribution width and the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention. Verdoia M, Barbieri L, Schaffer A, Cassetti E, Di Giovine G, Bellomo G, Marino P, Sinigaglia F, De Luca G. J Thromb Thrombolysis; 2014 Apr; 37(3):345-52. PubMed ID: 23793523 [Abstract] [Full Text] [Related]
9. Comparison of homocysteinemia and MTHFR 677CT polymorphism with Framingham Coronary Heart Risk Score. Gariglio L, Riviere S, Morales A, Porcile R, Potenzoni M, Fridman O. Arch Cardiol Mex; 2014 Apr; 84(2):71-8. PubMed ID: 24793554 [Abstract] [Full Text] [Related]
19. Genetic polymorphism of 5,10-MTHFR reductase gene in offspring of patients with myocardial infarction. Margaglione M, Colaizzo D, Cappucci G, del Popolo A, Vecchione G, Grandone E, Di Minno G. Thromb Haemost; 1999 Jul; 82(1):19-23. PubMed ID: 10456448 [Abstract] [Full Text] [Related]
20. Hyperhomocysteinemia is a risk factor of recurrent coronary event in young patients irrespective to the MTHFR C677T polymorphism. Gonzalez-Porras JR, Martin-Herrero F, Garcia-Sanz R, Lopez ML, Balanzategui A, Mateos MV, Pavon P, Gonzalez M, Alberca I, San Miguel JF. Thromb Res; 2007 Jul; 119(6):691-8. PubMed ID: 17005242 [Abstract] [Full Text] [Related] Page: [Next] [New Search]